AbC-19™ Rapid Test is a COVID-19 neutralising antibody test CE marked for professional use in the United Kingdom and the European Union (EU), as well as FDA cleared for distribution to CLIA certified labs in the USA.
The test can be administered by healthcare professionals, such as doctors, nurses, pharmacists and healthcare workers, and will detect SARS-CoV-2 IgG antibodies to the full spike protein following direct exposure to SARS-CoV-2 virus or vaccination.
AbC-19™ Rapid Test uses a small drop of blood from a finger-prick, and shows results in 20 minutes.
Results in 20 minutes from a small finger-prick of blood
AbC-19TM Rapid Test is 99.40% accurate, following the manufacture of tens of thousands of tests across multiple production scale batches. Testing was performed at Ulster University and at the laboratories of Abingdon Health.
In Oct 2020, the UK Government confirmed their first order of 1 million AbC-19TM Rapid Tests.
The test is available for large scale commercial distribution but is not available for individuals to purchase at the moment. Click register below to contact us about your commercial interest in AbC-19TM Rapid Test.
Download the AbC-19TM White Paper to learn the test will play an invaluable role in the strategy to combat SARS-CoV-2.
If you are interested in commercial distribution of the test, please register here. The AbC-19TM COVID-19 rapid antibody test is currently available for professional use only and not available for purchase by individuals.